RG

Rajesh Garg

Director DIN 03293988
DIN 03293988 First appointment Oct 2010
Unlock full profile Investments Β· shareholding Β· contact details
Past companies 2 historical roles
Total affiliations 2 Since Oct 2010
Shareholding value β€’β€’β€’β€’ Premium profile

About Rajesh Garg

Data last updated:

Rajesh Garg was an Additional Director at Dr. Jaikaran Biotech Pvt. Ltd (from 2010) and Additional Director at Wondrous Tradex Private Limited (from 2011).

DIN 03293988
First Appointment 18 Oct 2010
Oldest Company Age 20 yrs

Previous companies

CompanyDesignationAppointmentFoundedRevenueStatus
Dr. Jaikaran Biotech Pvt. Ltd U74991DL2006PTC148992
Additional Director18 Oct 20102006Strike Off
Wondrous Tradex Private Limited U51217DL2010PTC209934
Additional Director25 Aug 20112010Strike Off

Explore Director's current and past company associations Uncover their professional journey today!

Directorship timeline

Open interactive timeline →
Dr. Jaikaran Biotech Pvt. Ltd
Wondrous Tradex Private Limited
Premium access

Shareholding and investment profile for Rajesh Garg

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Rajesh Garg

Rajesh Garg was first appointed on 18 Oct 2010 as Additional Director at Dr. Jaikaran Biotech Pvt. Ltd. The most recent appointment on record is 25 Aug 2011 at Wondrous Tradex Private Limited.

Rajesh Garg held 2 earlier board appointments: Dr. Jaikaran Biotech Pvt. Ltd (Additional Director, from 18 Oct 2010); Wondrous Tradex Private Limited (Additional Director, from 25 Aug 2011).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available